These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 29935114

  • 1. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning.
    Cima LN, Martin SC, Lambrescu IM, Stejereanu L, Zaharia C, Colita A, Fica S.
    J Pediatr Endocrinol Metab; 2018 Aug 28; 31(8):869-878. PubMed ID: 29935114
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thyroid Disorders Following Hematopoietic Stem Cell Transplantation in Childhood: Impact of Conditioning Regimen on Thyroid Dysfunction, Volume Changes, and Occurrence of Nodules.
    Cattoni A, Molinari S, Gaiero A, De Lorenzo P, Fichera G, Riva B, Di Marco S, Tommesani C, Mariani E, Medici F, Pagni F, Nicolosi ML, Fraschini D, Napolitano S, Rovelli A, Biondi A, Valsecchi MG, Balduzzi A.
    Transplant Cell Ther; 2022 Aug 28; 28(8):506.e1-506.e12. PubMed ID: 35660063
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Subclinical hypothyroidism in children and adolescents after hematopoietic stem cells transplantation without irradiation.
    Milenković T, Vujić D, Vuković R, Zečević Ž, Soldatović I, Mitrović K, Todorović S, Zdravković D.
    Vojnosanit Pregl; 2014 Dec 28; 71(12):1123-7. PubMed ID: 25639000
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases.
    Somali M, Mpatakoias V, Avramides A, Sakellari I, Kaloyannidis P, Smias C, Anagnostopoulos A, Kourtis A, Rousso D, Panidis D, Vagenakis A.
    Gynecol Endocrinol; 2005 Jul 28; 21(1):18-26. PubMed ID: 16048797
    [Abstract] [Full Text] [Related]

  • 8. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.
    Bizzarri C, Pinto RM, Ciccone S, Brescia LP, Locatelli F, Cappa M.
    Pediatr Blood Cancer; 2015 Sep 28; 62(9):1650-5. PubMed ID: 26017459
    [Abstract] [Full Text] [Related]

  • 9. Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning.
    Gherman RF, Ewald S, Ihorst G, Strüßmann T, Zeiser R, Wäsch R, Bertz H, Stolz D, Duyster J, Finke J, Marks R, Engelhardt M, Duque-Afonso J.
    Eur J Haematol; 2024 Mar 28; 112(3):350-359. PubMed ID: 37823328
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
    Ishida H, Adachi S, Hasegawa D, Okamoto Y, Goto H, Inagaki J, Inoue M, Koh K, Yabe H, Kawa K, Kato K, Atsuta Y, Kudo K.
    Pediatr Blood Cancer; 2015 May 28; 62(5):883-9. PubMed ID: 25545836
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience.
    Hamidieh AA, Alimoghaddam K, Jahani M, Bahar B, Mousavi SA, Iravani M, Behfar M, Jalali A, Jalili M, Hamdi A, Ghavamzadeh A.
    J Pediatr Hematol Oncol; 2013 Aug 28; 35(6):e239-45. PubMed ID: 23042019
    [Abstract] [Full Text] [Related]

  • 18. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G, Labopin M, Beohou E, Dalissier A, Dalle JH, Cornish J, Zecca M, Samarasinghe S, Gibson B, Locatelli F, Bertrand Y, Abdel-Rahman F, Socie G, Sundin M, Lankester A, Sedlacek P, Hamladji RM, Heilmann C, Afanasyev B, Hough R, Peters C, Bader P, Veys P.
    Biol Blood Marrow Transplant; 2017 Mar 28; 23(3):467-474. PubMed ID: 27916512
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis.
    Yamamoto W, Andou T, Itabashi M, Koyama S, Ishii Y, Numata A, Motohashi K, Hagihara M, Matsumoto K, Fujisawa S.
    Intern Med; 2016 Mar 28; 55(13):1721-7. PubMed ID: 27374671
    [Abstract] [Full Text] [Related]

  • 20. Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
    Ingram W, Devereux S, Das-Gupta EP, Russell NH, Haynes AP, Byrne JL, Shaw BE, McMillan A, Gonzalez J, Ho A, Mufti GJ, Pagliuca A.
    Br J Haematol; 2008 Apr 28; 141(2):235-43. PubMed ID: 18318762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.